Your browser doesn't support javascript.
loading
Efficacy and safety results of depatuxizumab mafodotin (ABT-414) in patients with advanced solid tumors likely to overexpress epidermal growth factor receptor.
Goss, Glenwood D; Vokes, Everett E; Gordon, Michael S; Gandhi, Leena; Papadopoulos, Kyriakos P; Rasco, Drew W; Fischer, JuDee S; Chu, Katharine L; Ames, William W; Mittapalli, Rajendar K; Lee, Ho-Jin; Zeng, Jiewei; Roberts-Rapp, Lisa A; Loberg, Lise I; Ansell, Peter J; Reilly, Edward B; Ocampo, Christopher J; Holen, Kyle D; Tolcher, Anthony W.
Afiliação
  • Goss GD; The Ottawa Hospital Research Institute and the University of Ottawa, Ottawa, Ontario, Canada.
  • Vokes EE; Department of Medicine, University of Chicago, Chicago, Illinois.
  • Gordon MS; HonorHealth Research Institute, Scottsdale, Arizona.
  • Gandhi L; New York University Perlmutter Cancer Center, NYU Health, New York, New York.
  • Papadopoulos KP; South Texas Accelerated Research Therapeutics, San Antonio, Texas.
  • Rasco DW; South Texas Accelerated Research Therapeutics, San Antonio, Texas.
  • Fischer JS; AbbVie, Inc, North Chicago, Illinois.
  • Chu KL; AbbVie, Inc, North Chicago, Illinois.
  • Ames WW; AbbVie, Inc, North Chicago, Illinois.
  • Mittapalli RK; AbbVie, Inc, North Chicago, Illinois.
  • Lee HJ; AbbVie, Inc, North Chicago, Illinois.
  • Zeng J; AbbVie, Inc, North Chicago, Illinois.
  • Roberts-Rapp LA; AbbVie, Inc, North Chicago, Illinois.
  • Loberg LI; AbbVie, Inc, North Chicago, Illinois.
  • Ansell PJ; AbbVie, Inc, North Chicago, Illinois.
  • Reilly EB; AbbVie, Inc, North Chicago, Illinois.
  • Ocampo CJ; AbbVie, Inc, North Chicago, Illinois.
  • Holen KD; AbbVie, Inc, North Chicago, Illinois.
  • Tolcher AW; South Texas Accelerated Research Therapeutics, San Antonio, Texas.
Cancer ; 124(10): 2174-2183, 2018 05 15.
Article em En | MEDLINE | ID: mdl-29533458
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos da Visão / Imunoconjugados / Fadiga / Anticorpos Monoclonais Humanizados / Neoplasias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos da Visão / Imunoconjugados / Fadiga / Anticorpos Monoclonais Humanizados / Neoplasias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article